In a screening exam involving over 240 receptors, the researchers observed that conolidine shown binding for the ACKR3 receptor in equally humans and mice, stopping ACKR3 from binding to opioid peptides.Researchers feel that blocking this scavenger receptor signifies that it might now not avoid Obviously developed opioids from interacting with othe